These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
237 related items for PubMed ID: 22342098
41. Postoperative radiotherapy of childhood medulloblastomas. Kocsis B, Székely G, Pap L, Takácsi-Nagy Z, Németh G. Neoplasma; 2001; 48(4):320-3. PubMed ID: 11712686 [Abstract] [Full Text] [Related]
42. Patterns of failure in children with medulloblastoma treated with 3D conformal radiotherapy. Skowrońska-Gardas A, Chojnacka M, Morawska-Kaczyńska M, Perek D, Perek-Polnik M. Radiother Oncol; 2007 Jul; 84(1):26-33. PubMed ID: 17560676 [Abstract] [Full Text] [Related]
50. Hyperfractionated accelerated radiotherapy in the Milan strategy for metastatic medulloblastoma. Gandola L, Massimino M, Cefalo G, Solero C, Spreafico F, Pecori E, Riva D, Collini P, Pignoli E, Giangaspero F, Luksch R, Berretta S, Poggi G, Biassoni V, Ferrari A, Pollo B, Favre C, Sardi I, Terenziani M, Fossati-Bellani F. J Clin Oncol; 2009 Feb 01; 27(4):566-71. PubMed ID: 19075266 [Abstract] [Full Text] [Related]
51. Intellectual outcome after reduced-dose radiation therapy plus adjuvant chemotherapy for medulloblastoma: a Children's Cancer Group study. Ris MD, Packer R, Goldwein J, Jones-Wallace D, Boyett JM. J Clin Oncol; 2001 Aug 01; 19(15):3470-6. PubMed ID: 11481352 [Abstract] [Full Text] [Related]
52. Clinical Outcomes Among Children With Standard-Risk Medulloblastoma Treated With Proton and Photon Radiation Therapy: A Comparison of Disease Control and Overall Survival. Eaton BR, Esiashvili N, Kim S, Weyman EA, Thornton LT, Mazewski C, MacDonald T, Ebb D, MacDonald SM, Tarbell NJ, Yock TI. Int J Radiat Oncol Biol Phys; 2016 Jan 01; 94(1):133-138. PubMed ID: 26700707 [Abstract] [Full Text] [Related]
53. A prospective study of cognitive function in children receiving whole-brain radiotherapy and chemotherapy: 2-year results. Packer RJ, Sutton LN, Atkins TE, Radcliffe J, Bunin GR, D'Angio G, Siegel KR, Schut L. J Neurosurg; 1989 May 01; 70(5):707-13. PubMed ID: 2709111 [Abstract] [Full Text] [Related]
56. Neuropsychologic functioning of survivors of childhood medulloblastoma randomized to receive conventional or reduced-dose craniospinal irradiation: a Pediatric Oncology Group study. Mulhern RK, Kepner JL, Thomas PR, Armstrong FD, Friedman HS, Kun LE. J Clin Oncol; 1998 May 01; 16(5):1723-8. PubMed ID: 9586884 [Abstract] [Full Text] [Related]
57. Association Between Brain Substructure Dose and Cognitive Outcomes in Children With Medulloblastoma Treated on SJMB03: A Step Toward Substructure-Informed Planning. Acharya S, Guo Y, Patni T, Li Y, Wang C, Gargone M, Ashford JM, Wilson L, Faught A, Reddick WE, Patay Z, Gajjar A, Conklin HM, Merchant TE. J Clin Oncol; 2022 Jan 01; 40(1):83-95. PubMed ID: 34714708 [Abstract] [Full Text] [Related]
58. Impact of craniospinal dose, boost volume, and neurologic complications on intellectual outcome in patients with medulloblastoma. Moxon-Emre I, Bouffet E, Taylor MD, Laperriere N, Scantlebury N, Law N, Spiegler BJ, Malkin D, Janzen L, Mabbott D. J Clin Oncol; 2014 Jun 10; 32(17):1760-8. PubMed ID: 24516024 [Abstract] [Full Text] [Related]
59. Survival and neurodevelopmental outcome of young children with medulloblastoma at St Jude Children's Research Hospital. Walter AW, Mulhern RK, Gajjar A, Heideman RL, Reardon D, Sanford RA, Xiong X, Kun LE. J Clin Oncol; 1999 Dec 10; 17(12):3720-8. PubMed ID: 10577843 [Abstract] [Full Text] [Related]